Taiwan has observed a 1.49 million (0.2%) increase in the research & development by business enterprise, pharmaceutical industry in current ppp $, which now stands at 619.94 million.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Taiwan
No matching regions
Similar regions to Taiwan
Business R&D pharmaceutical in current PPP $
Taiwan Business R&D pharmaceutical in current PPP $ between 1999 and 2022
Period | Business R&D pharmaceutical in current PPP $ | Change |
---|---|---|
2022 | 619.94M | +1.49M |
2021 | 618.45M | +52.65M |
2020 | 565.80M | +74.99M |
2019 | 490.81M | -13.33M |
2018 | 504.14M | -26.21M |
2017 | 530.35M | -4.99M |
2016 | 535.34M | +87.58M |
2015 | 447.76M | -28.75M |
2014 | 476.51M | +85.97M |
2013 | 390.54M | +44.40M |
2012 | 346.14M | +19.72M |
2011 | 326.42M | +65.80M |
2010 | 260.61M | +37.18M |
2009 | 223.44M | +18.08M |
2008 | 205.36M | +56.38M |
2007 | 148.98M | +16.90M |
2006 | 132.08M | +13.94M |
2005 | 118.14M | +13.59M |
2004 | 104.55M | +16.03M |
2003 | 88.52M | +3.05M |
2002 | 85.47M | +23.43M |
2001 | 62.03M | -10.69M |
2000 | 72.72M | +3.53M |
1999 | 69.20M |